Double Valve-in-Valve Transcatheter Valve Replacements for Failed Surgical Bioprosthetic Aortic and Tricuspid Valves

Author(s):  
Kyongjune B. Lee ◽  
Gregory D. Trachiotis ◽  
Jonathan S. Reiner ◽  
Christian D. Nagy

Transcatheter technology has revolutionized the treatment of valvular disease in the field of cardiology and cardiac surgery. We present an interesting case of a patient with prior double valve replacements, which had degenerated after a decade, with symptoms of decompensated heart failure. The patient was successfully treated with double valve-in-valve transcatheter aortic and tricuspid valve replacement.

2015 ◽  
Vol 44 (2) ◽  
pp. 74-78
Author(s):  
Tomonori Koga ◽  
Tatsuhiko Komiya ◽  
Hiroshi Tsuneyoshi ◽  
Takeshi Shimamoto

2017 ◽  
Vol 44 (3) ◽  
pp. 209-213 ◽  
Author(s):  
Pranav Loyalka ◽  
Angelo Nascimbene ◽  
Benjamin Metz ◽  
Igor D. Gregoric ◽  
Ajay Sundara Raman ◽  
...  

A few case reports and case series have documented the outcomes in patients with tricuspid bioprosthetic valvular degeneration who underwent transcatheter implantation of the Medtronic Melody and the Edwards Sapien XT and Sapien 3 valves. In this report, we describe the case of a 49-year-old woman with severe bioprosthetic tricuspid valvular stenosis and multiple comorbidities who underwent transcatheter tricuspid valve replacement with a Sapien 3 valve.


2014 ◽  
Vol 41 (5) ◽  
pp. 507-510 ◽  
Author(s):  
Ali Mortazavi ◽  
Ross M. Reul ◽  
Leon Cannizzaro ◽  
Kathryn G. Dougherty

We describe the case of a 38-year-old man with a history of metastatic testicular cancer who had undergone multiple thoracic surgical procedures, including tricuspid valve replacement with a bioprosthetic valve as a result of tricuspid involvement of his malignancy. He presented at our outpatient cardiology clinic with worsening fatigue, shortness of breath, and peripheral edema, investigation of which revealed severe tricuspid bioprosthesis stenosis with central regurgitation. Because of the patient's medical history, he was considered to be a high-risk surgical candidate. Therefore, transcatheter tricuspid valve-in-valve implantation of a 26-mm Edwards Sapien® valve was attempted through a transjugular approach. The procedure restored tricuspid valvar competence and substantially improved the patient's symptoms. We discuss the technical aspects of this case and briefly review the usefulness of the valve-in-valve technique in the tricuspid position.


1968 ◽  
Vol 21 (1) ◽  
pp. 98-99 ◽  
Author(s):  
Paul G. Gannon ◽  
Claude Grondin ◽  
Ernesto Molina ◽  
Richard L. Varco ◽  
Richard C. Lillehei ◽  
...  

2020 ◽  
Vol 11 (4) ◽  
pp. 411-416 ◽  
Author(s):  
Krishan Patel ◽  
Soraya Sadeghi ◽  
Jamil Aboulhosn

Background: We sought to describe invasive hemodynamic measurements in patients with tricuspid stenosis (TS) undergoing transcatheter tricuspid valve-in-valve (TVIV) implantation immediately pre- and postimplantation. Development of TS in patients who have undergone surgical tricuspid valve replacement with a bioprosthetic valve is a serious complication that leads to elevated right atrial (RA) pressures and decreased cardiac output. Transcatheter TVIV implantation is a viable alternative to surgical tricuspid valve replacement, but data on the hemodynamic consequences of TVIV for the treatment of severe TS are currently limited to echocardiographic assessment of Doppler-derived gradients. Methods: Eleven patients undergoing transcatheter TVIV implantation with moderate to severe bioprosthetic valve stenosis were selected for retrospective review. Right atrial mean pressure, right ventricular (RV) systolic and end-diastolic pressure, mean diastolic RA-RV pressure gradient, pulmonary artery capillary wedge pressure, pulmonary artery systolic, end-diastolic and mean pressures, and pulmonary artery pulsatility index (PAPi) both before and after transcatheter valve placement were collected from catheterization reports. Results: After transcatheter TVIV implantation, the mean TS gradient decreased significantly ( P < .01), while the mean RV end-diastolic pressure increased ( P = .046). Pulmonary artery pulsatility index also increased as the TS was relieved ( P = .039). Conclusions: Tricuspid valve-in-valve implantation results in immediate relief of TS, leading to increased RV preload with resultant augmentation of RV and pulmonary pressures. Increased PAPi following the procedure demonstrates acute improvement in RV output but remains low due to the failure of the RA pressure to decline significantly immediately following intervention.


Sign in / Sign up

Export Citation Format

Share Document